All News #Library
Biotech
Grace Science, FDA START For NGLY1 Gene Therapy GS-100, 2nd Patient Treated
03 Jun 2024 //
BUSINESSWIRE
Grace Science Announces First Patient Treated in Phase 1/2/3 Trial of GS-100
05 Mar 2024 //
BUSINESSWIRE

Market Place
Sourcing Support